Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

STO/ARCOMA stock hub

STO/ARCOMA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/ARCOMAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

106.5M

Nasdaq Stockholm

Market data

Price

Recent price action with selectable time range.

STO/ARCOMASTO/ARCOMA

—

Loading chart…

In the news

Latest news · STO/ARCOMA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.1

P25 n/aP50 n/aP75 n/a

Trailing P/E28.6

P25 n/aP50 n/aP75 n/a

ROE5.5

P25 n/aP50 n/aP75 n/a

ROIC9.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/ARCOMA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

210

Groups with data

Currency

SEK

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	31
Employees Change	0%
Employees Change Percent	0
Enterprise value	SEK 72.5M
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Medical Devices
Isin	SE0006219176
Last refreshed	2026-05-10
Market cap	SEK 106.5M
Price	SEK 7.44
Price currency	SEK
Rev Per Employee	4,094,612.9x
Sector	Healthcare
Sic	3845
Symbol	sto/ARCOMA
Website	https://www.arcoma.se

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.57%
EV Earnings	19.1x
EV/EBIT	15.53x
EV/EBITDA	15.89x
EV/FCF	3.47x
EV/Sales	0.57x
FCF yield	19.64%
Forward P/E	11.1x
P/B ratio	1.41x
P/E ratio	28.59x
P/S ratio	0.84x
PE Ratio3 Y	47.98x
PE Ratio5 Y	56.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.68%
EBITDA Margin	3.6%
FCF margin	16.47%
Gross margin	39.85%
Gross Profit	SEK 50.6M
Gross Profit Growth	-17.11%
Gross Profit Growth Q	-11.42%
Gross Profit Growth3 Y	-0.4%
Gross Profit Growth5 Y	2.04%
Net Income	SEK 3.8M
Net Income Growth	-60.57%
Net Income Growth Q	-60.32%
Net Income Growth Years	0%
Net Income Growth3 Y	69.7%
Pretax Margin	3.74%
Profit Margin	2.99%
Profit Per Employee	SEK 122,484
Profitable Years	4
ROA	3.01
Roa5y	2.8
ROCE	6.18
ROE	5.55
Roe5y	4.38
ROIC	9.21
Roic5y	6.38

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.75%
Cagr1y	-17.34%
Cagr3y	-3.19%
Cagr5y	-18.59%
EPS Growth	-64.36
EPS Growth Q	-63.44
EPS Growth Years	0
EPS Growth3 Y	63.7
FCF Growth	82.86%
FCF Growth3 Y	36.21%
FCF Growth5 Y	111.67%
OCF Growth	86.79%
OCF Growth3 Y	37.1%
OCF Growth5 Y	112.4%
Revenue Growth	-13.15x
Revenue Growth Q	-8.4x
Revenue Growth Years	0x
Revenue Growth3 Y	-2.83x
Revenue Growth5 Y	0.98x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 1.31
Assets	SEK 101.8M
Cash	SEK 33.9M
Current Assets	SEK 82M
Current Liabilities	SEK 26.3M
Equity	SEK 75.5M
Interest Coverage	42.06
Liabilities	SEK 26.3M
Long Term Assets	SEK 19.8M
Long Term Liabilities	SEK 0
Net Cash	SEK 33.9M
Net Cash By Market Cap	SEK 31.88
Net Cash Growth	313.98%
Net Debt EBITDA	SEK -7.44
Net Debt Equity	SEK -0.45
Net Debt FCF	SEK -1.62
Tangible Book Value	SEK 75.5M
Tangible Book Value Per Share	SEK 5.28
WACC	7.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.12
Inventory Turnover	2.69
Net Working Capital	SEK 21.8M
Quick ratio	2.04
Working Capital	SEK 55.7M
Working Capital Turnover	SEK 2.7

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.65%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	44.47%
1Y total return	-17.33%
200-day SMA	8.29
3Y total return	-9.27%
50-day SMA	8.02
50-day SMA vs 200-day SMA	50under200
5Y total return	-64.23%
All Time High	26.3
All Time High Change	-71.71%
All Time High Date	2021-01-07
All Time Low	3.57
All Time Low Change	108.4%
All Time Low Date	2017-01-26
ATR	0.43
Beta	0.59
Beta1y	-0.03
Beta2y	0.22
Ch YTD	1.36
High	7.44
High52	11
High52 Date	2025-07-31
High52ch	-32.36%
Low	7.16
Low52	6.16
Low52 Date	2026-02-12
Low52ch	20.78%
Ma50ch	-7.23%
Price vs 200-day SMA	-10.21%
RSI	42.48
RSI Monthly	41.01
RSI Weekly	42.07
Sharpe ratio	-0.27x
Sortino ratio	-0.26
Total Return	-10.65%
Tr YTD	1.36
Tr1m	-8.6%
Tr1w	-2.36%
Tr3m	-2.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK 4.7M
Operating Income Growth	-60.5
Operating Income Growth Q	-59.57
Operating Income Growth3 Y	27.57
Operating Income Growth5 Y	32.41
Operating margin	3.68

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11,933,937%
Shares Insiders	6.26%
Shares Out	14,308,510
Shares Qo Q	0%
Shares Yo Y	10.65%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK 20.9M
Average Volume	7,288.45x
Bv Per Share	5.28
CAPEX	SEK -449,000
Ch10y	44.47
Ch1m	-8.6
Ch1w	-2.36
Ch1y	-17.33
Ch3m	-2.11
Ch3y	-9.27
Ch5y	-64.23
Ch6m	-2.36
Change	0.27%
Change From Open	1.92
Close	7.42
Days Gap	-1.62
Depreciation Amortization	-105,000
Dollar Volume	108,058.6
Earnings Date	2026-04-14
EBIT	SEK 4.7M
EBITDA	SEK 4.6M
EPS	SEK 0.26
F Score	5
FCF	SEK 20.9M
FCF EV Yield	28.83x
FCF Per Share	SEK 1.46
Financing CF	10,362,000
Fiscal Year End	December
Founded	1,990
Graham Number	5.56007
Graham Upside	-25.27
Income Tax	SEK 948,000
Investing CF	-4,907,000
Is Primary Listing	1
Last Earnings Date	2026-04-14
Last Report Date	2026-03-31
Lynch Fair Value	SEK 6.51
Lynch Upside	-12.55
Ma150	7.92
Ma150ch	-6.1%
Ma20	7.92
Ma20ch	-6.05%
Net CF	25,743,000
Next Earnings Date	2026-08-20
Open	7.3
P FCF Ratio	5.09
P OCF Ratio	4.99
Position In Range	100
Ppne	1,300,000
Price Date	2026-05-08
Price EBITDA	SEK 23.33
Ptbv Ratio	1.41
Relative Volume	2.13x
Revenue	126,933,000x
Tax By Revenue	0.75x
Tax Rate	19.98%
Tr6m	-2.36%
Volume	14,524

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STO/ARCOMA pay a dividend?

Capital-return profile for this ticker.

Performance

STO/ARCOMA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/ARCOMA?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+6.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+10.6%

Negative means the company is buying back shares.

Technical

STO/ARCOMA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.5

Neutral momentum band

Price vs 200-day MA

-10.2%

50/200-day relationship not available

Beta (5Y)

0.59

Less volatile than the market

Sharpe ratio

-0.27

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/ARCOMA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/ARCOMA stock rating?

sto/ARCOMA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/ARCOMA analysis?

The full report lives at /stocks/sto/ARCOMA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/ARCOMA?

The latest report frames sto/ARCOMA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/ARCOMA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.